Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 18.
doi: 10.1007/s11547-025-02065-0. Online ahead of print.

Italian adaptation of the European guidelines for breast cancer diagnosis, staging, and preoperative planning: a GRADE-ADOLOPMENT approach

Collaborators, Affiliations

Italian adaptation of the European guidelines for breast cancer diagnosis, staging, and preoperative planning: a GRADE-ADOLOPMENT approach

Paola Mantellini et al. Radiol Med. .

Abstract

An Italian guideline panel issued the national recommendations for breast cancer diagnosis, staging, and preoperative planning. The panel employed the ADOLOPMENT process to adopt or adapt the guidelines developed by the European Commission Initiative on Breast Cancer (ECIBC). This process utilises the Grading of Recommendations Assessment, Development and Evaluation evidence-to-decision framework. Hereby, we present 15 prioritised recommendations from the second chapter of the Italian guidelines. All of the recommendations as originally developed by the ECIBC were adopted. For the assessment of women with positive screening result, the diagnostic recommendations suggest using digital breast tomosynthesis instead of additional mammographic projections. Recommendations include using needle core biopsy (NCB) instead of fine-needle aspiration for suspicious lesions, and stereotactic-guided -rather than ultrasound-guided- NCB for suspicious calcifications. For preoperative planning, they recommend clip marking after biopsy and not using additional magnetic resonance imaging (MRI) for confirmed ductal carcinoma in situ. Contrast-enhanced mammography is preferred over MRI for presurgical planning, when needed. Other imaging tests are not recommended for stage I, IIa, and IIb BC without signs of metastasis, while positron emission tomography-computed tomography alone is suggested for stage III BC. Adjuvant hormone therapy is recommended when 1% or more tumour cells show oestrogen or progesterone receptor positivity, which replaces the 10% threshold. Adopting shared and trustworthy guidelines for BC screening across Europe will help standardise the process across settings and advance healthcare quality and equity.

Keywords: ADOLOPMENT; Breast cancer; GRADE approach; Italy; Screening.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interests: Silvia Deandrea is President of the GISMa. Marco Rosselli Del Turco is a former medical consultant for senology to the FORA s.p.a. Paolo Giorgi Rossi and Livia Giordano are members of the panel that developed the European guidelines on breast cancer screening and diagnosis, which is the reference document for the ADOLOPMENT process. Vittorio Cannatà is former Vice-President of the Italian Association of Medical Physics (AIFM). Isabella Castellano has been professional consultant for the “Choosing the best therapy in ER + /HER2- breast cancer” symposium (token of attendance at the National Congress of Anatomic Pathology, October 2019), Myriad Genetics, s.r.l. Stefano Pacifici is President of the Italian Association of Senology Radiographers (AITeRS). Annalisa Trianni is member of the Italian Association of Medical Physics (AIFM). Paola Golinelli was reimbursed for participation in the European Federation of Organization for Medical Physics (EFOMP) Working Group on mammographic tomosynthesis equipments. The other authors have no relevant financial or non-financial interest to disclose. All panellists were required to disclose all financial, non-financial, personal, and institutional interests relevant to the scope of the guidelines by completing a standardised form, following the guidance from the SNLG. The Scientific Committee assessed each individual interest, and no panellist was excluded from the voting procedures. This policy was upheld throughout the entire process, including the selection of panel members, the generation and prioritization of research questions, and the participation in the formulation of recommendations. The Scientific Committee consistently monitored the declaration of conflicts of interest. Ethical approval: This article does not contain any studies with human participants or animals performed by any of the authors. For this type of studies (guidelines/position paper), ethics approval is not required. Consent for publication: For this type of studies (guidelines/position paper), consent for publication is not required. Informed consent: For this type of studies (guidelines/position paper), formal informed consent is not required.

References

    1. European Commission (2025) ECIS. European Cancer Information System. https://ecis.jrc.ec.europa.eu/en . Accessed 14 Nov 2024
    1. Duffy SW, Tabár L, Yen AM et al (2020) Mammography screening reduces rates of advanced and fatal breast cancers: results in 549,091 women. Cancer 126:2971–2979. https://doi.org/10.1002/cncr.32859 - DOI - PubMed
    1. The Independent UK Panel on Breast Cancer Screening, Marmot MG, Altman DG et al (2013) The benefits and harms of breast cancer screening: an independent review: a report jointly commissioned by Cancer Research UK and the Department of Health (England) October 2012. Br J Cancer 108:2205–2240. https://doi.org/10.1038/bjc.2013.177 - DOI - PMC
    1. Schünemann HJ, Lerda D, Quinn C et al (2020) Breast cancer screening and diagnosis: a synopsis of the European breast guidelines. Ann Intern Med 172:46. https://doi.org/10.7326/M19-2125 - DOI - PubMed
    1. Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L (2008) European guidelines for quality assurance in breast cancer screening and diagnosis -summary document. Oncol Clin Pract 4(2):74–86. https://doi.org/10.1093/annonc/mdm481 - DOI

LinkOut - more resources